New research published in the BMJ shows that angiotensin receptor blockers (ARBs), commonly used to treat high blood pressure and heart disease, could protect against Alzheimer's disease. The study from the University of Boston looked at predominantly male participants (98%) with cardiovascular disease over the age of 65. The findings also show that ARBs could slow the progression of Alzheimer's disease or dementia, reducing incidence of early death or admission to nursing homes - helping people with dementia to maintain independence for longer... (Source: Health News from Medical News Today)